Practice Variation in Infective Endocarditis Prophylaxis for Pediatric and Congenital Heart Disease Patients with Cardiac Implantable Electronic Devices: An International Survey - Summary - MDSpire
Advertisement
Practice Variation in Infective Endocarditis Prophylaxis for Pediatric and Congenital Heart Disease Patients with Cardiac Implantable Electronic Devices: An International Survey
To assess global practice patterns related to infective endocarditis (IE) prophylaxis among clinicians caring for pediatric and congenital patients with cardiac implantable electronic devices (CIEDs) and to describe clinician-reported experience with CIED-associated IE.
Approach:
Study Design: A cross-sectional, descriptive study using an anonymous, web-based survey distributed to members of the Pediatric and Congenital Electrophysiology Society (PACES).
Survey Population: Approximately 200 PACES members were invited to participate, focusing on physicians and advanced practice providers involved in managing pediatric or adult congenital heart disease patients with CIEDs.
Survey Development: The survey was developed by a multidisciplinary group of pediatric electrophysiologists and included multiple-choice and categorical questions across various domains related to IE prophylaxis practices.
Key Findings:
Current guidelines for IE prophylaxis are primarily based on adult data, which may not fully apply to pediatric and congenital heart disease populations.
The survey aimed to capture clinician-reported practices and experiences with device-related IE in both pediatric and adult populations.
Interpretation:
Understanding current practice patterns may help identify areas of uncertainty and inform future pediatric-specific recommendations.
Limitations:
Responses were not stratified by patient age, limiting the ability to analyze practices specific to pediatric versus adult populations.
Geographic location, institutional characteristics, and practice setting could not be analyzed due to anonymization.
Conclusion:
The study highlights the need for further investigation into IE prophylaxis practices in pediatric and congenital heart disease patients with CIEDs.